Literature DB >> 24391410

Renoprotective effects of Vitamin D and renin-angiotensin system.

A Koroshi1, A Idrizi1.   

Abstract

Vitamin D has many physiological functions. First it is a primary regulator of calcium homeostasis. Beyond that, vitamin D and its receptors (VDR) play important role in the immune system, cardiovascular system, reproductive system and insulin resistance. An important aspect of vitamin D pleiotropic effects is the interaction with components of the renin-angiotensin system (RAS). It was demonstrated that vitamin D-null mice have a sustained elevation of renin expression. The combination of both the AT1 blockers and the vitamin D analogues, leads to a marked amelioration of the molecular and clinical markers of diabetic nephropathy. This combination may protect the kidney through the effects on both the glomerular and the tubulointerstitial compartments. There are different studies that corroborate the renoprotective action of vitamin D in CKD. In fact the renoprotective mechanisms in humans remain to be assessed, but these are realized through reduction of proteinuria, high blood pressure, inflammation as well as hemodynamic effects. An important mechanism is the role of vitamin D as a potent negative endocrine regulator of renin expression. It was shown that low levels of vitamin D represent a novel risk factor for the progression of renal disease but it is not demonstrated yet that vitamin D can prolong the time to end-stage renal disease. This question remains to be answered in other future controlled clinical trials.

Entities:  

Keywords:  angiotensin II; chronic kidney disease; renin-angiotensin system; review; vitamin D

Year:  2011        PMID: 24391410      PMCID: PMC3876844     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  25 in total

1.  Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia.

Authors:  Y C Li; A E Pirro; M Amling; G Delling; R Baron; R Bronson; M B Demay
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Ultraviolet B and blood pressure.

Authors:  R Krause; M Bühring; W Hopfenmüller; M F Holick; A M Sharma
Journal:  Lancet       Date:  1998-08-29       Impact factor: 79.321

3.  Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets.

Authors:  O Dardenne; J Prud'homme; A Arabian; F H Glorieux; R St-Arnaud
Journal:  Endocrinology       Date:  2001-07       Impact factor: 4.736

4.  Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning.

Authors:  T Yoshizawa; Y Handa; Y Uematsu; S Takeda; K Sekine; Y Yoshihara; T Kawakami; K Arioka; H Sato; Y Uchiyama; S Masushige; A Fukamizu; T Matsumoto; S Kato
Journal:  Nat Genet       Date:  1997-08       Impact factor: 38.330

5.  Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.

Authors:  Steven Fishbane; Harini Chittineni; Michal Packman; Paula Dutka; Nicole Ali; Nicole Durie
Journal:  Am J Kidney Dis       Date:  2009-07-12       Impact factor: 8.860

6.  A rare haplotype of the vitamin D receptor gene is protective against diabetic nephropathy.

Authors:  Rosalind J L Martin; Amy J McKnight; Christopher C Patterson; Denise M Sadlier; Alexander P Maxwell
Journal:  Nephrol Dial Transplant       Date:  2009-09-27       Impact factor: 5.992

7.  Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.

Authors:  A A Geisterfer; M J Peach; G K Owens
Journal:  Circ Res       Date:  1988-04       Impact factor: 17.367

8.  Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial.

Authors:  Cheuk-Chun Szeto; Kai-Ming Chow; Bonnie Ching-Ha Kwan; Kwok-Yi Chung; Chi-Bon Leung; Philip Kam-Tao Li
Journal:  Am J Kidney Dis       Date:  2008-04-03       Impact factor: 8.860

9.  Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals.

Authors:  Natalya Bodyak; Juan Carlos Ayus; Steven Achinger; Venkatesha Shivalingappa; Qingen Ke; Yee-Shiuan Chen; Debra L Rigor; Isaac Stillman; Hector Tamez; Paul E Kroeger; Ruth R Wu-Wong; S Ananth Karumanchi; Ravi Thadhani; Peter M Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

10.  Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial.

Authors:  Pooneh Alborzi; Nina A Patel; Carla Peterson; Jennifer E Bills; Dagim M Bekele; Zerihun Bunaye; Robert P Light; Rajiv Agarwal
Journal:  Hypertension       Date:  2008-07-07       Impact factor: 10.190

View more
  4 in total

Review 1.  Emerging Role of Nitric Oxide and Heat Shock Proteins in Insulin Resistance.

Authors:  Marisa Nile Molina; León Ferder; Walter Manucha
Journal:  Curr Hypertens Rep       Date:  2016-01       Impact factor: 5.369

Review 2.  Hypertension and insulin resistance: implications of mitochondrial dysfunction.

Authors:  Walter Manucha; Bob Ritchie; León Ferder
Journal:  Curr Hypertens Rep       Date:  2015-01       Impact factor: 5.369

3.  Vitamin D Regulates the Expressions of AQP-1 and AQP-4 in Mice Kidneys.

Authors:  Yu Fu; Jiajun Zhu; Yalin Zhang; Zuwang Liu; Han Su; Juan Kong
Journal:  Biomed Res Int       Date:  2019-01-27       Impact factor: 3.411

4.  Vitamin D and Calcium Supplementation Accelerate Vascular Calcification in a Model of Pseudoxanthoma Elasticum.

Authors:  Elise Bouderlique; Ellie Tang; Jeremy Zaworski; Amélie Coudert; Dominique Bazin; Ferenc Borondics; Jean-Philippe Haymann; Georges Leftheriotis; Ludovic Martin; Michel Daudon; Emmanuel Letavernier
Journal:  Int J Mol Sci       Date:  2022-02-19       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.